Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S2W-25914 · Session 2

How many hospital patients have venous thrombosis; what percentage of patients receive appropriate prevention treatment, and what action is…

Answered Asked by Nanette Milne Con Lodged 12 May 2006

The question

To ask the Scottish Executive how many hospital patients have venous thrombosis; what percentage of patients receive appropriate prevention treatment, and what action is being taken to educate hospital staff on the extent of venous thromboembolism.

The answer

Answered by Andy Kerr on 25 May 2006 · 13 days after it was lodged, on time

It is not possible, from centrallyheld hospital discharge records, to identify explicitly patients who acquired venousthrombosis whilst in hospital. The figures given in the table describe the numberof patients in Scotland discharged from hospital with a main or secondary conditionof venous thrombosis. These figures will include people who acquire venous thrombosisin hospital but may also include patients admitted with venous thrombosis.
AcuteHospital (Non-Obstetric, Non-Psychiatric) In-Patient/Day Case Discharges with anyDiagnosis of Venous Thrombosis (Years Ending 31 March 2001 to 2005)
2001
| 7,047

2002
| 6,869

2003
| 6,886

2004
| 6,421

2005
| 6,069

Source: ISD. The data relateto the following International Classification of Diseases 10th revision (ICD10)codes:
GO8.X: Intracranial and intraspinalphlebitis and thrombophlebitis.
126: Pulmonary Embolism.
163.6: Cereb infarct due cerebralvenous thrombosi, nonpyogenic.
167.6: Nonpyogenic thrombosisof intracranial venous system.
180: Phlebitis and thrombophlebitis.
181: Portal vein thrombosis.
182.2: Embolism and thrombosisof vena cava.
182.3: Embolism and thrombosisof renal vein.
182.8: Embolism and thrombosisof other specified veins.
182.9: Embolism and thrombosisof unspecified vein.
K75.1: Phlebitis of portal vein.
O22.2: Superficial thrombophlebitisin pregnancy.
O22.3: Deep phlebothrombosisin pregnancy.
O22.5: Cerebral venous thrombosisin pregnancy.
O87.0: Superficial thrombophlebitisin the puerperium.
O87.1: Deep phlebothrombosisin the puerperium.
O87.3: Cerebral venous thrombosisin the puerperium.
Data on the percentage of patientsreceiving appropriate prevention treatment is not held centrally. The Scottish Surveillanceof HAI Programme (SSHAIP), a national audit of surgical site infection, does, however,include data on the number of orthopaedic patients receiving prophylaxis for venousthromboembolism (VTE), in accordance with SIGN Guideline 62. The SSHAIP data showthat 91% of such patients receive prophylaxis. This can be regarded as indicativeof coverage in orthopaedic patients in general, a group particularly at risk ofVTE.
In addition, maternity unitsin Scotland are working to local protocols for VTE, covering bothprophylaxis and treatment, based on guidelines from the Royal College of Obstetricsand Gynaecology and SIGN Guideline 62.
NHS Quality Improvement Scotlandintends to carry out an exercise taking stock of all the initiatives in place inNHSScotland across different clinical specialties aimed at preventing VTE. The resultswill help to determine how best to raise awareness amongst hospital staff.

In the Official Report

No contribution in the Official Report cites S2W-25914 by reference.